American Institutes of Health AIDS research funding to abandon the quota

Over the past 20 years, the US National Institutes of Health (NIH) has funded AIDS research were fixed in 10% of the overall budget. However, this year NIH funding will reduce this level. The latest fund funding success rates reflects a motivation to abandon the reserved quota: In many organizations, access to AIDS research funding than non-AIDS research funding much easier, and this shows that government officials are doing everything possible to find the money to spend Method.

In the early 1990s, when the AIDS epidemic is still in the stage of the outbreak, the US Congress and NIH agreed annually section NIH AIDS research budget devoted to stabilizing at about 10%. However, since then, racking their brains to find some agencies spend AIDS funding approaches, sometimes even extend the definition of AIDS research, or relax standards. Recently, some members of Congress questioned this: when AIDS deaths in the United States have begun to decline, to provide special treatment for this disease is still make sense?

Last year, NIH Dean Francis Collins announced that AIDS funding agency will focus more directly to steering vaccines and treatments. In December, after the consent of the consent of Congress, NIH formally renounced quota of 10% of the funding.

The results from the NIH's budget request for fiscal year 2017 can be seen. This year, the agency funded AIDS research with the amount of $ 3 billion in 2015 was flat, and is expected to remain at that level in 2017. Since last year's NIH budget grew by nearly 7%, and are demanding a further increase next year's budget, and therefore will be assigned to the portion of AIDS research in 2015 down to 10% this year, 9.3% next year it may be reduced to 9%.